Upcoming events
William Wijns

William Wijns

Interventional cardiologist / Cardiologist
The Lambe Institute for Translational Medicine and Curam - Galway, Ireland

EDUCATION RESPONSIBILITIES AND MEETING ORGANISATION

Currently, William Wijns is SFI (Science Foundation Ireland) Professor in Interventional Cardiology at the Lambe Institute for Translational Medicine, Curam, and Saolta University Healthcare Group, National University of Ireland Galway. He has served the ESC in various positions, including Vice-President, Scientific Programme Chair, and was also a President of the  European Association of Percutaneous Cardiac Intervention (EAPCI). Presently, William Wijns is Co-Director of EuroPCR and Chairman of PCR.

Diplomas

YearDiploma
1976 - 1981Cardiologist - University of Louvain, Belgium (Prof. J-M. Detry)
1981First applications of nuclear cardiology, thrombolysis and coronary dilatation - Thorax Center, Rotterdam, The Netherlands (Prof. P. Hugenholtz)
1986Clinical Professor of Cardiology

Clinical career

YearFunction + center
1984 - 1985Visiting Associate Professor of Radiological Sciences UCLA (Prof. H. Schelbert)
1986Director of the cardiac PET programme (reserach on regulation of coronary blood flow and cardiac metabolism in ischemic heart disease) - University of Louvain, Belgium
1994 - 2016Co-Director of the Cardiovascular Center Aalst and interventional cardiologist (also involved with the clinical applications of non-invasive coronary angiography with the use of multislice computed tomography)
Since 2016SFI Professor in Interventional Cardiology (SFI stands for Science Foundation Ireland)

Declaration of interest

FunctionCompany
HonorariumAstrazeneca
HonorariumBoston Scientific
HonorariumBristol Myers Squibb
HonorariumCordis Cardiac & Vascular Institute
HonorariumEdwards Lifesciences
HonorariumEli Lilly
HonorariumGlaxosmithkline
HonorariumOrbusNeich
HonorariumTerumo
Grants/research supportAbbott Vascular
Grants/research supportAblynx
Grants/research supportBiosensors International
Grants/research supportBiotronik
Grants/research supportBoston Scientific
Grants/research supportBristol Myers Squibb
Grants/research supportCapella
Grants/research supportCardio3 Biosciences
Grants/research supportConormed
Grants/research supportCordis Cardiac & Vascular Institute
Grants/research supportDevax
Grants/research supportGlaxosmithkline
Grants/research supportMedtronic
Grants/research supportOrbusNeich
Grants/research supportPrescient
Grants/research supportSorin Group

Latest contributions

Magmaris Magnesium BRS: safety and performance of an advanced and innovative technology

16 May 2017 – From EuroPCR 2017

Consult this session presented by M. Joner, W. Wijns and M.K.Y. Lee if you want to find out more about the best indication for patient selection in 2017, ultrathin, bioresorbable polymer sirolimus-eluting stents vs thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisatio; the new update on Dual Antiplatelet Therapy (DAPT) VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI from the ESC 2017 and more...

PCR Board Members receive recognition at ESC Congress 2017

William Wijns, PCR Chair and EuroPCR and AfricaPCR Co-Director, and Marie-Claude Morice, Senior Consulting Adviser to EuroPCR, were both distinguished at ESC Congress 2017 in Barcelona for their outstanding contributions to the advancement of cardiovascular medicine.

EuroPCR 2017 Closing Ceremony

19 May 2017 – From EuroPCR 2017

Coronary interventions LIVE demonstration: PCI for very long lesion

19 May 2017 – From EuroPCR 2017

EuroPCR 2017 Best Abstract Award - PCR's Got Talent

19 May 2017 – From EuroPCR 2017

Consult this session & presentation of the EuroPCR 2017 Best Abstract Award. M. Haude announces the winner of the 2017 PCR's got talent competition.

Lessons from PCI complications

19 May 2017 – From EuroPCR 2017

Out of the box innovative technologies

18 May 2017 – From EuroPCR 2017

Late-breaking trials and trial updates

18 May 2017 – From EuroPCR 2017

Consult this session on Late-breaking trials and trial updates at EuroPCR 2017 to find out more about a randomised multicentre trial to evaluate the utilisation of revascularisation or optimal medical therapy for the treatment of coronary CTO (EuroCTO), results from the COMPARE-ACUTE trial, neurological complications after TAVI and Bioresorbable scaffolds vs. metallic stents in routine coronary intervention on the AIDA study.

BVS: reviewing the evidence and distilling the learnings

18 May 2017 – From EuroPCR 2017

Introduction to polymer technology - What is relevant for the interventional cardiologist

17 May 2017 – From EuroPCR 2017

Firehawk DES: proven fast healing from TARGET clinical programme

17 May 2017 – From EuroPCR 2017

Bioresorbable scaffolds: an evolving technology

17 May 2017 – From EuroPCR 2017

Coronary interventions LIVE demonstration: left main PCI

17 May 2017 – From EuroPCR 2017

EuroPCR Innovators Day tackles heart failure, software disruption and “trial fatigue”

16 May 2017

Fostering collaboration between “all the stakeholders of the innovation eco-system” was the key aim of yesterday’s EuroPCR Innovators Day, according to Facilitator and Course co-Director William Wijns. As well as a focus on devices, this year’s session included a “significant” focus on “debate devoted to the discussion of processes and changes in the landscape of our innovation ecosystem,” he explained.

EuroPCR 2017: weaving the fabric of our speciality from 40 years of balloon angioplasty to the future

16 May 2017

Dear colleague, dear companion, we wish each of you a warm Welcome home.

The beginning of a meeting is both a joyous and solemn occasion. A vital link has been created that draws us all together, making each one of us active players in an endeavour which grows, matures and advances by the participation of all.

Can we imagine what our professional world would be like today if this did not happen? If our teachers, our pioneers, our inventors had not been there with us? If we did not have the collaboration of visionary engineers, investors, and industry, all sharing the vision of our best clinicians?

Where would we be today if the physicians who came before us had not had the insight to seek new, patient-centred approaches—in our case an endovascular one—to constantly improve the care we offer our patients?

What about the patients themselves who have given us their trust, and who have been open to the new procedures we propose? Where would we be if we were working alone?

Statement from PCR: status of BRS technology and clinical use

16 May 2017 – From EuroPCR 2017

2017 Ethica Award

16 May 2017 – From EuroPCR 2017

The 2017 Ethica Award, the highest honour of the European cardiovascular intervention academies celebrates people who have made an outstanding contribution to interventional patient care. Join H. Amin and J. Fajadet who will present this year's Ethica Award ceremony during EuroPCR 2017.

Late-breaking trials and trial updates

16 May 2017 – From EuroPCR 2017

Davide Capodanno

Chairperson

Davide Capodanno
William Wijns

Chairperson

William Wijns

A complex multivessel and calcified disease

16 May 2017 – From EuroPCR 2017

Consult this session on calcified coronary lesion and complex multivessel PCI, that includes a LIVE demonstration from National University Heart Centre - Singapore. A 69-year-old male patient.

Clinical case

A 69-year-old male with multivessel disease:
- Calcified lesions
- RCA and LAD treated with rot ablation
- IVUS assessment

EuroPCR 2017 Opening Ceremony

16 May 2017 – From EuroPCR 2017

A warm welcome from the Course Directors J. Bax, J. Fajadet, W. Wijns to everyone attending the 2017 edition of EuroPCR that marks 40 years in Angioplasty. Enjoy the Course!

Forty years of interventional innovation: what is the next big thing?

15 May 2017 – From PCR Innovators Day Paris 2017

Welcome introduction

15 May 2017 – From PCR Innovators Day Paris 2017

Discover the latest innovative and disruptive technologies and key opinion leaders in interventional cardiology during the opening ceremony by W Wijns during PCR Innovators Day Paris 2017.

How we arrived here: understanding the BVS bioresorbable coronary scaffold today

01 Mar 2017

The special article by Patrick W. Serruys and Yoshinobu Onuma on the impact of implantation techniques for the BVS bioresorbable coronary scaffold deserves a word of introduction.

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W. Wojakowski, Poland and W.H. Yin.

Prof. Tian-Hai Koh

Chairperson

Tian Hai KOH
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul

Optimizing complex lesions via transradial approaches

20 Jan 2017

William Wijns

Chairperson

William Wijns

All you need to know about BRS

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Prof. Huay Cheem Tan

Chairperson

Huay Cheem Tan
William Wijns

Chairperson

William Wijns

Left main treatment based on new clinical evidence: PCI or CABG?

15 Dec 2016 – From GulfPCR-GIM 2016

Moheeb Al Abdullah

Chairperson

Moheeb Al Abdullah

Chairperson

Talib Majwal
William Wijns

Chairperson

William Wijns

Opening ceremony of GulfPCR-GIM 2016

14 Dec 2016 – From GulfPCR-GIM 2016

Consult this opening ceremony of GulfPCR-GIM 2016 if you want to learn more about the changes in the interventional landscape, new data in left main PCI, mid-term outcomes of bioresorbable scaffolds, progress in structural and valvular interventions and continued interest in clinical research.

Dr. Ibrahim Al-Rasdan

Chairperson

Ibrahim Al Rashdan
Dr. Haitham Amin

Chairperson

Haitham Amin
Prof. Thomas Cuisset

Chairperson

Thomas Cuisset
Dr. Jean Fajadet

Chairperson

Jean Fajadet

Current issues and unmet needs of DES in modern PCI practices - From long-term safety and efficacy point of view

23 Jan 2015 – From AsiaPCR/SingLIVE 2015